NeoMed is a market leader in the neonatal enteral market servicing over 40% of all NICU beds in the US with elements of our product line.
NeoMed is proud to announce that our “low dose” ENFit™ syringe design solution has gained the acceptance of the industry group (GEDSA) and is expected to become the “global solution” that resolves those concerns regarding low volume medication dosing accuracy. NeoMed’s experience designing innovative delivery devices for Pharmacy, NICU and PICU led to syringe tip design modifications that address volume delivery variances raised with the original ENFit™ dimensional specifications.
Industry support for this “low dose” design is evidenced by the statement below: “The clinical community has voiced its concerns regarding the potential impact the current design may have with respect to low dose administration of medication. In response to these issues, GEDSA has identified a solution that it believes will eliminate the risk of improper dosing. The specifications of, and access to the intellectual property rights to this design have been provided to GEDSA’s members.” Learn More »